Literature DB >> 23255565

Racial variation in toll-like receptor variants among women with pelvic inflammatory disease.

Brandie D Taylor1, Toni Darville, Robert E Ferrell, Roberta B Ness, Catherine L Haggerty.   

Abstract

BACKGROUND: Racial disparities exist in gynecological diseases. Variations in Toll-like receptor (TLR) genes may alter signaling following microbial recognition.
METHODS: We explored genotypic differences in 6 functional variants in 4 TLR genes (TLR1, TLR2, TLR4, TLR6) and the adaptor molecule TIRAP between 205 African American women and 51 white women with clinically suspected pelvic inflammatory disease (PID). A permutated P < .007 was used to assess significance. Associations between race and endometritis and/or upper genital tract infection (UGTI) were explored. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: The TT genotype for TLR1 rs5743618, the GG genotype for TLR1 rs4833095, the CC genotype for TLR2 rs3804099, the TLR6 rs5743810 T allele, and the CC genotype for TIRAP rs8177374 significantly differed between races (P < .007). African American race was associated with endometritis and/or UGTI (OR, 4.2 [95% CI, 2.0-8.7]; P = .01). Among African Americans, the TLR6 rs5743810 T allele significantly decreased endometritis and/or UGTI (OR, 0.4 [95% CI, .2-.9]; P = .04). Additionally, rs5743618, rs4833095, and rs8177374 increased endometritis and/or UGTI, albeit not significantly.
CONCLUSIONS: Among women with PID, TLR variants that increase inflammation are associated with African American race and may mediate the relationship between race and endometritis and/or UGTI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255565      PMCID: PMC3571443          DOI: 10.1093/infdis/jis922

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Effect of acute pelvic inflammatory disease on fertility.

Authors:  L Weström
Journal:  Am J Obstet Gynecol       Date:  1975-03-01       Impact factor: 8.661

2.  Chlamydia positivity in women screened in family planning clinics: racial/ethnic differences and trends in the northwest U.S., 1997-2006.

Authors:  David Fine; Katherine K Thomas; Wendy Nakatsukasa-Ono; Jeanne Marrazzo
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

3.  Contribution of major diseases to disparities in mortality.

Authors:  Mitchell D Wong; Martin F Shapiro; W John Boscardin; Susan L Ettner
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

4.  Black-white differences in infectious disease mortality in the United States.

Authors:  J H Richardus; A E Kunst
Journal:  Am J Public Health       Date:  2001-08       Impact factor: 9.308

5.  Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6.

Authors:  E D Cox; S C Hoffmann; B S DiMercurio; R A Wesley; D M Harlan; A D Kirk; P J Blair
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

6.  Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis.

Authors:  N B Kiviat; P Wølner-Hanssen; D A Eschenbach; J N Wasserheit; J A Paavonen; T A Bell; C W Critchlow; W E Stamm; D E Moore; K K Holmes
Journal:  Am J Surg Pathol       Date:  1990-02       Impact factor: 6.394

7.  Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.

Authors:  Roberta B Ness; David E Soper; Robert L Holley; Jeffrey Peipert; Hugh Randall; Richard L Sweet; Steven J Sondheimer; Susan L Hendrix; Antonio Amortegui; Giuliana Trucco; Thomas Songer; Judith R Lave; Sharon L Hillier; Debra C Bass; Sheryl F Kelsey
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

8.  Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling.

Authors:  Raina N Fichorova; Amanda O Cronin; Egil Lien; Deborah J Anderson; Robin R Ingalls
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

9.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

10.  Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.

Authors:  Toni Darville; Joshua M O'Neill; Charles W Andrews; Uma M Nagarajan; Lynn Stahl; David M Ojcius
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

View more
  12 in total

Review 1.  The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.

Authors:  Kerry Murphy; Caroline M Mitchell
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

2.  Toll-like receptor variants and cervical Atopobium vaginae infection in women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Patricia A Totten; Sabina G Astete; Michael J Ferris; David H Martin; Roberta B Ness; Catherine L Haggerty
Journal:  Am J Reprod Immunol       Date:  2017-12-29       Impact factor: 3.886

3.  Interactive effect of TLR SNPs and exposure to sexually transmitted infections on prostate cancer risk in Jamaican men.

Authors:  Bhawna Dubey; Maria Jackson; Charnita Zeigler-Johnson; Karthik Devarajan; Rafael E Flores-Obando; Norma McFarlane-Anderson; Marshall Tulloch-Reid; William Aiken; Kevin Kimbro; Dominique Reed; LaCreis R Kidd; Denise Gibbs; Sudhir Kumar; Camille Ragin
Journal:  Prostate       Date:  2020-09-07       Impact factor: 4.104

4.  Association of Toll-like receptor polymorphisms with HIV status in North Americans.

Authors:  B Willie; N B Hall; C M Stein; R J Jurevic; A Weinberg; R K Mehlotra; P A Zimmerman
Journal:  Genes Immun       Date:  2014-09-25       Impact factor: 2.676

5.  Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design.

Authors:  Timo Smieszek; Peter J White
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

6.  Effect of smoking on the genetic makeup of toll-like receptors 2 and 6.

Authors:  Muhammad Kohailan; Mohammad Alanazi; Mahmoud Rouabhia; Abdullah Alamri; Narasimha Reddy Parine; Abdullah Alhadheq; Santhosh Basavarajappa; Abdul Aziz Abdullah Al-Kheraif; Abdelhabib Semlali
Journal:  Onco Targets Ther       Date:  2016-11-21       Impact factor: 4.147

Review 7.  Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review.

Authors:  Dongmei Wang; Yue Jiang; Jiaxing Feng; Jingshu Gao; Jinlan Yu; Jing Zhao; Pihong Liu; Yaguang Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-19       Impact factor: 2.629

8.  Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity.

Authors:  Rodolfo D Vicetti Miguel; Stephen A K Harvey; William A LaFramboise; Seth D Reighard; Dean B Matthews; Thomas L Cherpes
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

9.  TRAIL-R1 is a negative regulator of pro-inflammatory responses and modulates long-term sequelae resulting from Chlamydia trachomatis infections in humans.

Authors:  Mufadhal Al-Kuhlani; James Rothschild; James Rothchild; Sukumar Pal; Luis M de la Maza; Sander Ouburg; Servaas A Morré; Deborah Dean; David M Ojcius
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

10.  Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination.

Authors:  Laura Choteau; Hélène Vancraeyneste; Didier Le Roy; Laurent Dubuquoy; Luiginia Romani; Thierry Jouault; Daniel Poulain; Boualem Sendid; Thierry Calandra; Thierry Roger; Samir Jawhara
Journal:  Gut Pathog       Date:  2017-02-15       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.